Scholars Central

ArticlePublished Mar 2015

Vitiligo

Authors: Alexander KC Leung, Benjamin Barankin

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Case: A 21-year-old man presented with white macules and patches on his lower lip and chin for the past 5 years. The lesions were asymptomatic but cosmetically unsightly. His health was otherwise unremarkable. There was no family history of a similar skin disorder or autoimmune disease. Vitiligo is a common acquired pigmentation disorder characterized by depigmented macules and patches as a result of loss of functional cutaneous melanocytes. The condition affects 0.5 to 1% of the population worldwide. Approximately 25% of affected patients have the onset of vitiligo before the age of 10 years and 50% before the age of 20 years. Genetic, immunological, and neurogenic factors may act alone or synergistically to trigger or perpetuate the loss of functional melanocytes from the basal layer of the epidermis. Typically, vitiligo presents as acquired amelanotic macules and patches that appear chalk or milk-white in color. Lesions often show homogenous depigmentation and are well demarcated. Lesions are often symmetrical and enlarge centrifugally in size with time.best replica watches The most common location is the face, followed by the neck, lower limbs, trunk, and upper limbs. The diagnosis is mainly clinical, based on the findings of acquired, well-demarcated white macules and patches that tend to enlarge. Wood’s lamp accentuates the lesion and may be of benefit in the diagnosis (e.g. to differentiate from tinea versicolor or pityriasis alba), especially in individuals with skin type I and type II. The clinical course is generally unpredictable. In individuals with skin type I and type II, no active treatment other than the use of camouflage cosmetics and sunscreens is usually recommended. Psychological support should be offered when necessary. If treatment is preferred for cosmetic reasons, a variety of treatment options are available. These include topical corticosteroids, topical calcineurin inhibitors, narrowband ultraviolet B phototherapy (nbUVB), and monochromatic excimer laser and light at 308 nm.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in International Journal of Clinical & Medical Images.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Clinical & Medical Images
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Alexander KC Leung”
  • BylineArticles whose byline prints “Benjamin Barankin”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels